Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1804372Generated: October 25, 2026

(R)-4-Methyloxazolidin-2-one → (R)-3-{3-(1,1-dioxoisothiazolidin-2-yl)-4-[4-(5-ethyl-3-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one

https://huagongshe.com/reaction/1804372

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(R)-4-Methyloxazolidin-2-oneHCID 2734858—
Reactant[4-Bromo-2-(1,1-dioxoisothiazolidin-2-yl)phenyl][4-(5-ethyl-3-methylpyridin-2-yl)piperazin-1-yl]methanoneHCID 58484567—
Product(R)-3-{3-(1,1-dioxoisothiazolidin-2-yl)-4-[4-(5-ethyl-3-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-oneHCID 5848480389.9%

Reaction Steps

By reaction and treatment in the same manner as in Example 149 and using [4-bromo-2-(1,1-dioxoisothiazolidin-2-yl)phenyl][4-(5-ethyl-3-methylpyridin-2-yl)piperazin-1-yl]methanone (507 mg) described in Preparation Example 180 and (R)-4-methyloxazolidin-2-one (121 mg) described in Preparation Example 25, the title compound (474 mg) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08354401B2
Source datasetuspto-grants-2013_01
ORD IDord-ce49af48513348f993e2bf7545e05355
Source noteuspto-grants-2013_01